DAVITA INC. (DVA)

NYSE · SEC-listed source profile

Listing facts

SEC issuer name
DAVITA INC.
Ticker
DVA
Exchange
NYSE
Instrument family
Ordinary share
SEC issuer CIK
0000927066
Listing source refreshed
2026-09-13
Reviewed security class
Common Stock, $0.001 par value

SEC listing source

IEX reference history

Recent completed-session IEX reference closes for this current listing. The chart shows raw, unadjusted single-exchange observations rather than a consolidated U.S. market close.

DAVITA INC. recent IEX single-exchange reference closing-price history22 observations from Aug 20, 2026 to Sep 21, 2026. Values range from 173.87 to 194.
Unadjusted IEX reference closes · Aug 20, 2026–Sep 21, 2026 · 22 observations · per share
IEX Historical Data Terms

Screened reference metrics

These percentage measures use the same qualified observation window and normalize only explicitly registered positive split events. They are reference metrics, not total returns or benchmark-relative performance.

Window return
4.01%
Aug 20, 2026–Sep 21, 2026
Range width
11.58%
Screened closing-price range
Latest range position
41.83%
Position within screened close range
Average close vs. start
3.49%
Average screened close relative to starting close
About this market data

IEX historical data reflects IEX activity only and is presented as a source-scoped reference point, not as consolidated U.S. market history.

Screened reference metrics use K9-qualified IEX reference history and only explicitly registered positive split events. They do not assert complete split history, consolidated U.S. market performance, or canonical adjusted prices.

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

The raw chart can show a discontinuity around a stock split because it is intentionally unadjusted. The screened metrics use only explicitly registered positive split events and do not assert complete split history.

Company Research Map

These reviewed encyclopedia concepts are supported by public-company evidence for this business. Operating-model groups show how the reported concepts fit together without implying that every metric in the broader model is reported by this issuer.

Research coverage

Start with an operating model, then move into the supported concepts and economic bridges below. Coverage counts describe reviewed evidence links for this issuer, not standardized KPI completeness.

Dialysis Provider Economics

17 reviewed concepts

Connect treatment activity, reimbursement per treatment, patient-care cost, modality and payor mix, collections, network footprint, market share, and segment profitability across a dialysis provider.

How these metrics connect

These bridges come from the reviewed operating model. Linked concepts have public-company evidence for this issuer; broader bridge coverage remains explicit when the model contains additional concepts.

Treatment volume, patient base, and network footprint
8 of 8 reviewed concepts

Treatment volume, average daily treatments, treatment days, patient count, outpatient centers, hospital service contracts, market share, and normalized non-acquired growth show the operating scale and underlying demand base. Center count and patient count are point-in-time measures, while treatments are period activity.

Reimbursement, payor mix, and care setting
6 of 6 reviewed concepts

Average patient service revenue per treatment shows blended reimbursement, government and commercial revenue mix show payor economics, and outpatient, home-based, and hospital inpatient revenue mix show where care is delivered. Revenue shares are not interchangeable with patient or treatment shares.